Centre forms committee to examine WHO details on 66 kid deaths in The Gambia
Darpan News Desk IANS, 12 Oct, 2022 11:00 AM
New Delhi, Oct 12 (IANS) The Centre has formed a four-member panel to examine the detailed report shared by the World Health Organisation on 66 children's deaths in The Gambia reportedly after using Indian-made medicines.
"The committee will examining and analysing adverse event reports, causal relationship, and all related details shared by WHO. After examining, the committee will suitably advise and recommend the Drug Controller General of India (DCGI) about further course of action. The committee may co-opt any other technical expert as deemed necessary, an official source told IANS.
The WHO had issued an alert on four India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 deaths among children in Gambia".
The committee will be chaired by Dr Y.K Gupta, Vice Chairperson, Standing National Committee on Medicines. The other members are Dr Pragya D. Yadav, NIV, ICMR, Pune, Dr Arti Bahl, Division of Epidemiology, NCDC, New Delhi, and A.K. Pradhan, JDC(I), CDSCO.
The WHO has informed that as per the tentative results received by it, out of the 23 samples of the products under reference which were tested, four samples have been found to contain Diethylene Glycol/Ethylene Glycol.
However, the global health body has not yet made available the certificate of analysis. It has informed that the same will be made available in near future. The exact one to one causal relation of death has not yet been provided by the WHO to the Central Drugs Standard Control Organisation (CDSCO) although it has requested the global health body twice in this regard, sources told IANS.
After the CDSCO launched a detailed investigation to ascertain the facts, the preliminary enquiry has revealed that Maiden Pharmaceutical Ltd, Sonepat, Haryana is a manufacturer licensed by the State Drug Controller for products Promethazine Oral Solution BP, Kofexnalin Baby Cough Syrup, MaKoff Baby Cough Syrup, and MaGrip n Cold Syrup under reference, and holds manufacturing permission for these products for export only. The company has manufactured and exported these products only to The Gambia.
Meanwhile, the CDSCO and State Drug Controller Haryana have stopped all the manufacturing activities of Maiden Pharmaceuticals Ltd at Sonepat on October 11 on grounds of deficiencies found on local inspection.
The police have also recovered an illegal weapon and live cartridge from the criminal. The accused has been identified as Aakash, a native of Muzaffarnagar in Uttar Pradesh.
The Punjab Police informed Delhi Police that the location of one of the phone numbers was traced to Delhi, and that the accused were changing their locations frequently. Acting on the tip-off, Delhi Police followed the leads obtained through technical surveillance and digital footprints.
SSP Mohali, Vivek Sheel Soni said, the two accused identified as Gagandeep Singh alias Gaagi and Gurpreet Singh alias Gopi are residents of Dabbwali in Sirsa district of Haryana.
The Punjab police will take him by a bulletproof car which will be escorted by a dozen cars full of cops. More than 50 police personnel will escort the vehicles to make sure no untoward incident takes place.
Badal said immediately after becoming the Chief Minister, Mann "had not only sublet governance of the state" to Delhi Chief Minister Arvind Kejriwal but had also failed to conduct a thanksgiving tour of his constituency as well as the Sangrur parliamentary seat that had elected him to the Lok Sabha twice.
On Monday, Gandhi was questioned by agency officials for several hours. He was given a lunch break after three hours, and went to meet his mother, and Congress President Sonia Gandhi, who is undergoing treatment at Sir Ganga Ram Hospital.
